Kevin M. Picardat

Array ( [id] => 6664099 [patent_doc_number] => 20030203425 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-30 [patent_title] => 'Hybrid glycosylated products and their production and use' [patent_app_type] => new [patent_app_number] => 10/257549 [patent_app_country] => US [patent_app_date] => 2003-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 19915 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 31 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20030203425.pdf [firstpage_image] =>[orig_patent_app_number] => 10257549 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6825575 [patent_doc_number] => 20030236197 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-25 [patent_title] => 'Modulators of beta-amyloid peptide aggregation' [patent_app_type] => new [patent_app_number] => 10/395290 [patent_app_country] => US [patent_app_date] => 2003-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 25856 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0236/20030236197.pdf [firstpage_image] =>[orig_patent_app_number] => 10395290 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6847397 [patent_doc_number] => 20030166564 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Methods of treating intestinal ischemia using heparin-binding epidermal growth factor' [patent_app_type] => new [patent_app_number] => 10/395540 [patent_app_country] => US [patent_app_date] => 2003-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6547 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20030166564.pdf [firstpage_image] =>[orig_patent_app_number] => 10395540 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 630564 [patent_doc_number] => 07132525 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-11-07 [patent_title] => 'Hypersensitive response elicitor fragments eliciting a hypersensitive response and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/387806 [patent_app_country] => US [patent_app_date] => 2003-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 18 [patent_no_of_words] => 19510 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 167 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/132/07132525.pdf [firstpage_image] =>[orig_patent_app_number] => 10387806 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6769989 [patent_doc_number] => 20030215929 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-20 [patent_title] => 'Rhodococcus gene encoding aldoxime dehydratase' [patent_app_type] => new [patent_app_number] => 10/387094 [patent_app_country] => US [patent_app_date] => 2003-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14165 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20030215929.pdf [firstpage_image] =>[orig_patent_app_number] => 10387094 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7359124 [patent_doc_number] => 20040014183 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-22 [patent_title] => 'Secondary metabolite congener distribution modulation' [patent_app_type] => new [patent_app_number] => 10/376612 [patent_app_country] => US [patent_app_date] => 2003-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 7707 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20040014183.pdf [firstpage_image] =>[orig_patent_app_number] => 10376612 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 505197 [patent_doc_number] => 07202211 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-04-10 [patent_title] => 'Methods of preventing or treating brain ischemia or brain injury' [patent_app_type] => utility [patent_app_number] => 10/371725 [patent_app_country] => US [patent_app_date] => 2003-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14757 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/202/07202211.pdf [firstpage_image] =>[orig_patent_app_number] => 10371725 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6846998 [patent_doc_number] => 20030166165 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins' [patent_app_type] => new [patent_app_number] => 10/361376 [patent_app_country] => US [patent_app_date] => 2003-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 28408 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20030166165.pdf [firstpage_image] =>[orig_patent_app_number] => 10361376 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6660158 [patent_doc_number] => 20030134802 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-17 [patent_title] => 'Novel effectors of dipepetidyl peptidase IV' [patent_app_type] => new [patent_app_number] => 10/361956 [patent_app_country] => US [patent_app_date] => 2003-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5985 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20030134802.pdf [firstpage_image] =>[orig_patent_app_number] => 10361956 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1073768 [patent_doc_number] => 06838433 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-01-04 [patent_title] => 'IL-6 antagonist peptides' [patent_app_type] => utility [patent_app_number] => 10/357479 [patent_app_country] => US [patent_app_date] => 2003-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 5989 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/838/06838433.pdf [firstpage_image] =>[orig_patent_app_number] => 10357479 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6797471 [patent_doc_number] => 20030176345 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'Wound healing composition and method for use thereof' [patent_app_type] => new [patent_app_number] => 10/356151 [patent_app_country] => US [patent_app_date] => 2003-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4962 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20030176345.pdf [firstpage_image] =>[orig_patent_app_number] => 10356151 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 578062 [patent_doc_number] => 07452690 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-11-18 [patent_title] => 'Protease EFC cell surface fusion protein assay' [patent_app_type] => utility [patent_app_number] => 10/353280 [patent_app_country] => US [patent_app_date] => 2003-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 8181 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 202 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/452/07452690.pdf [firstpage_image] =>[orig_patent_app_number] => 10353280 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7346469 [patent_doc_number] => 20040192594 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-30 [patent_title] => 'Modified neurotoxins as therapeutic agents for the treatment of diseases and methods of making' [patent_app_type] => new [patent_app_number] => 10/352335 [patent_app_country] => US [patent_app_date] => 2003-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11384 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20040192594.pdf [firstpage_image] =>[orig_patent_app_number] => 10352335 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5016830 [patent_doc_number] => 20070260039 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-08 [patent_title] => 'Methods of Producing Silk Polypeptides and Products Thereof' [patent_app_type] => utility [patent_app_number] => 10/501183 [patent_app_country] => US [patent_app_date] => 2003-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 22751 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20070260039.pdf [firstpage_image] =>[orig_patent_app_number] => 10501183 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6856676 [patent_doc_number] => 20030130177 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-10 [patent_title] => 'Use of amylin agonists to modulate triglycerides' [patent_app_type] => new [patent_app_number] => 10/337979 [patent_app_country] => US [patent_app_date] => 2003-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5561 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20030130177.pdf [firstpage_image] =>[orig_patent_app_number] => 10337979 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 975596 [patent_doc_number] => 06933274 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-08-23 [patent_title] => 'Methods for treatment of diabetes using a peptide analogues of insulin' [patent_app_type] => utility [patent_app_number] => 10/339160 [patent_app_country] => US [patent_app_date] => 2003-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 30 [patent_no_of_words] => 9037 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/933/06933274.pdf [firstpage_image] =>[orig_patent_app_number] => 10339160 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 421915 [patent_doc_number] => 07273846 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-09-25 [patent_title] => 'Selective melanin-concentrating hormone type-1 receptor agonists' [patent_app_type] => utility [patent_app_number] => 10/500672 [patent_app_country] => US [patent_app_date] => 2003-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10141 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/273/07273846.pdf [firstpage_image] =>[orig_patent_app_number] => 10500672 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 435782 [patent_doc_number] => 07262037 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-08-28 [patent_title] => 'Method for the production of D-(-)-3-hydroxybutyric acid by recombinant Escherichia coli' [patent_app_type] => utility [patent_app_number] => 10/336844 [patent_app_country] => US [patent_app_date] => 2003-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 2128 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/262/07262037.pdf [firstpage_image] =>[orig_patent_app_number] => 10336844 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6761896 [patent_doc_number] => 20030125258 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-03 [patent_title] => 'Bone polypeptide-1' [patent_app_type] => new [patent_app_number] => 10/327514 [patent_app_country] => US [patent_app_date] => 2002-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 21358 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0125/20030125258.pdf [firstpage_image] =>[orig_patent_app_number] => 10327514 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6851980 [patent_doc_number] => 20030144183 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'Synthetic glycosulfopeptides and methods of synthesis thereof' [patent_app_type] => new [patent_app_number] => 10/329068 [patent_app_country] => US [patent_app_date] => 2002-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 11108 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20030144183.pdf [firstpage_image] =>[orig_patent_app_number] => 10329068 [rel_patent_id] =>[rel_patent_doc_number] =>)